Demand for implantable medical devices will benefit from advances that should raise overall
confidence in these products, as well as a lack of alternative treatments for chronic disorders.
US demand to grow 7.7%
annually through 2015
US demand for implantable medical
devices is forecast to increase 7.7
percent annually to $52 billion in 2015,
benefiting from technological advances
and the development of next generation
devices that should increase patient and
provider confidence in implant products.
Demand will also benefit from the lack of
alternative treatments for many chronic
disorders and injuries. Over the long
term, sales for medical implants will be
challenged as insurance providers
tighten control over implantation costs.
However, the ability of medical implants
to reduce overall treatment cost for many
conditions, including osteoarthritis and
chronic heart failure, will promote growth
for these products.
Orthopedic implants to
remain largest segment
largest implantable device segment in
market value. US demand for orthopedic
implants is forecast to rise 8.8 percent
annually through 2015, spurred by
technological improvements and safety
enhancements. Gains will also reflect
the growing prevalence of degenerative
musculoskeletal disorders and lifestyle
changes that place people at risk for
sports and exercise injuries. At the same
time, as products become more durable
and long-lived, demand will increasingly
come from an enlarged patient base for
new surgeries rather than for replacements.
Also challenging this segment
over the long term will be advances in
pharmaceutical alternatives to treat
arthritic conditions. However, the segment
will benefit from a strong base of
insurance approvals for orthopedic
implants, as well as a stable and wellfunded
medical delivery system and
product designs that allow for less
invasive surgeries.
Pacing devices to realize
greatest sales gains in
cardiovascular segment
Cardiovascular implants have strong
potential to reduce the overall treatment
cost for heart disease, and at the same
time contribute significantly to improved
quality of life. Demand for these devices
is expected to grow 5.1 percent per year
through 2015. Pacing devices will realize
the greatest sales gains, largely due to
growth in cardiac resynchronization
therapy (CRT).
A focus on developing
new generations of pacing devices that
reduce mortality and improve patient
outcomes has resulted in greater pricing
flexibility in an increasingly cost-conscious
health care environment. Demand
for cardiovascular stents and related
devices will be similar to that of demand
for pacing devices. The fastest growth
will be in structural implants, as technological
advances in heart valves, ventricular-
assist devices and implantable
monitors will encourage greater use.
Study Scope
This study analyzes the $36 billion US implantable medical device industry. It presents historical demand data for the years 2000, 2005 and 2010, and forecasts for 2015 and 2020 by implant procedure, material and type (e.g., joint, spinal, orthobiologics, trauma, dental, pacing devices, stents, valves, ophthalmic, gynecological, drug, cosmetic).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 24 industry players, including Medtronic, Johnson & Johnson and Boston Scientific.
